213 related articles for article (PubMed ID: 34862657)
21. SPINK5 mutation and FLG gene deletion in an infant with Netherton syndrome.
Hacıhamdioğlu DÖ; Altan Ferhatoğlu Z; Karkucak M; Fişek İzci NM; Yakut T
Pediatr Int; 2022 Jan; 64(1):e15087. PubMed ID: 35438212
[No Abstract] [Full Text] [Related]
22. Desquamating Rash in a Patient with Undiagnosed Netherton Syndrome.
De Niear MA; Gigante J
J Pediatr; 2018 Jan; 192():262-262.e1. PubMed ID: 29106927
[No Abstract] [Full Text] [Related]
23. Netherton syndrome: Temporary response to dupilumab.
Aktas M; Salman A; Apti Sengun O; Comert Ozer E; Hosgoren Tekin S; Akin Cakici O; Demir G; Ergun T
Pediatr Dermatol; 2020 Nov; 37(6):1210-1211. PubMed ID: 32951242
[TBL] [Abstract][Full Text] [Related]
24. Clinical expression and new SPINK5 splicing defects in Netherton syndrome: unmasking a frequent founder synonymous mutation and unconventional intronic mutations.
Lacroix M; Lacaze-Buzy L; Furio L; Tron E; Valari M; Van der Wier G; Bodemer C; Bygum A; Bursztejn AC; Gaitanis G; Paradisi M; Stratigos A; Weibel L; Deraison C; Hovnanian A
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):575-82. PubMed ID: 22089833
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of interleukin-33 in the epidermis of two Japanese patients with Netherton syndrome.
Konishi T; Tsuda T; Sakaguchi Y; Imai Y; Ito T; Hirota S; Yamanishi K
J Dermatol; 2014 Mar; 41(3):258-61. PubMed ID: 24506793
[TBL] [Abstract][Full Text] [Related]
26. Novel SPINK5 variants in a patient with Netherton syndrome and intellectual disability. The diagnostic value of trichoscopy.
Schepis C; Failla P; Siragusa M; Vinci M; Calì F
G Ital Dermatol Venereol; 2020 Apr; 155(2):239-240. PubMed ID: 29781262
[No Abstract] [Full Text] [Related]
27. A heterozygous null mutation combined with the G1258A polymorphism of SPINK5 causes impaired LEKTI function and abnormal expression of skin barrier proteins.
Di WL; Hennekam RC; Callard RE; Harper JI
Br J Dermatol; 2009 Aug; 161(2):404-12. PubMed ID: 19438860
[TBL] [Abstract][Full Text] [Related]
28. A compound synonymous mutation c.474G>A with p.Arg578X mutation in SPINK5 causes splicing disorder and mild phenotype in Netherton syndrome.
Numata S; Teye K; Krol RP; Okamatsu Y; Hashikawa K; Matsuda M; Fortugno P; Di Zenzo G; Castiglia D; Zambruno G; Hamada T; Hashimoto T
Exp Dermatol; 2016 Jul; 25(7):568-70. PubMed ID: 26997095
[No Abstract] [Full Text] [Related]
29. Prenatal diagnosis of Comel-Netherton syndrome with PGD, case report and review article.
Bingol B; Tasdemir S; Gunenc Z; Abike F; Esenkaya S; Tavukcuoglu S; Berkil H
J Assist Reprod Genet; 2011 Jul; 28(7):615-20. PubMed ID: 21573681
[No Abstract] [Full Text] [Related]
30. A synonymous mutation in SPINK5 exon 11 causes Netherton syndrome by altering exonic splicing regulatory elements.
Fortugno P; Grosso F; Zambruno G; Pastore S; Faletra F; Castiglia D
J Hum Genet; 2012 May; 57(5):311-5. PubMed ID: 22377713
[TBL] [Abstract][Full Text] [Related]
31. Clinical and genetic characterization of Netherton syndrome due to SPINK5 founder variant in Latvian population.
Nartisa I; Kirsteina R; Neiburga KD; Zigure S; Ozola L; Grantina I; Micule I; Murmane D; Slisere B; Gailite L; Vilne B; Rots D; Taurina G; Kurjane N
Pediatr Allergy Immunol; 2023 Apr; 34(4):e13937. PubMed ID: 37102386
[TBL] [Abstract][Full Text] [Related]
32. [A lethal variant of Netherton syndrome in a large inbred family].
Capri Y; Vanlieferinghen P; Boeuf B; Dechelotte P; Hovnanian A; Lecomte B
Arch Pediatr; 2011 Mar; 18(3):294-8. PubMed ID: 21255986
[TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of a series of Israeli families with Comèl-Netherton syndrome.
Israeli S; Sarig O; Garty BZ; Indelman M; Bergman R; Sprecher E; Goldberg I
Dermatology; 2014; 228(2):183-8. PubMed ID: 24577329
[TBL] [Abstract][Full Text] [Related]
34. Novel splice site mutation at the C-terminal of SPINK5 cause a unique Netherton syndrome phenotype mimicking pustular psoriasis.
Hua S; Liu J; Fang B; Qian Q; Zhang J
J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):e113-e115. PubMed ID: 36165187
[No Abstract] [Full Text] [Related]
35. Comèl-Netherton syndrome defined as primary immunodeficiency.
Renner ED; Hartl D; Rylaarsdam S; Young ML; Monaco-Shawver L; Kleiner G; Markert ML; Stiehm ER; Belohradsky BH; Upton MP; Torgerson TR; Orange JS; Ochs HD
J Allergy Clin Immunol; 2009 Sep; 124(3):536-43. PubMed ID: 19683336
[TBL] [Abstract][Full Text] [Related]
36. The challenging management of a series of 43 infants with Netherton syndrome: unexpected complications and novel mutations.
Bellon N; Hadj-Rabia S; Moulin F; Lambe C; Lezmi G; Charbit-Henrion F; Alby C; Le Saché-de Peufeilhoux L; Leclerc-Mercier S; Hadchouel A; Steffann J; Hovnanian A; Lapillonne A; Bodemer C
Br J Dermatol; 2021 Mar; 184(3):532-537. PubMed ID: 32479644
[TBL] [Abstract][Full Text] [Related]
37. Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses.
Barbieux C; Bonnet des Claustres M; Fahrner M; Petrova E; Tsoi LC; Gouin O; Leturcq F; Nicaise-Roland P; Bole C; Béziat V; Bourrat E; Schilling O; Gudjonsson JE; Hovnanian A
J Allergy Clin Immunol; 2022 Apr; 149(4):1358-1372. PubMed ID: 34543653
[TBL] [Abstract][Full Text] [Related]
38. Ustekinumab therapy for Netherton syndrome.
Samuelov L; Shehadeh W; Sarig O; Gat A; Matz H; Sprecher E
J Dermatol; 2023 Apr; 50(4):494-499. PubMed ID: 36419401
[TBL] [Abstract][Full Text] [Related]
39. Dupilumab improves clinical symptoms in children with Netherton syndrome by suppressing Th2-mediated inflammation.
Yan S; Wu X; Jiang J; Yu S; Fang X; Yang H; Bai X; Wang H; Luo X
Front Immunol; 2022; 13():1054422. PubMed ID: 36569942
[TBL] [Abstract][Full Text] [Related]
40. Lethal Netherton syndrome due to homozygous p.Arg371X mutation in SPINK5.
Diociaiuti A; Castiglia D; Fortugno P; Bartuli A; Pascucci M; Zambruno G; El Hachem M
Pediatr Dermatol; 2013; 30(4):e65-7. PubMed ID: 23331056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
